Figure S3 | Related to Figure 3 bub1 deficiency reduces DCV entry.
A, bub1 knockdown efficiency in S2 * cells, measured by qRT-PCR. The change of expression was normalized to that of rfp dsRNA treated cells. B, bub1 knockdown in S2 * cells did not affect cell proliferation. Absorbance of OD450 was normalized to S2 * cells treated with gfp dsRNA at day one after 3 days post bub1dsRNA transfection. C, bub1 knockdown in S2 * cells did not affect cell viability. Absorbance of OD450 was normalized to S2 * cells treated with gfp dsRNA at each day, respectively. Characterization of DCV infection kinetics in Drosophila S2 * cells (D, E). D, DCV binding kinetic at different MOI. The solid line showed the linear regression, the dashed lines represents 95% confidence band of the best-fit line. r 2 =0.9862, p<0.0001. E, DCV entry kinetic at different time points with MOI=100. Solid line, non-linear regression was used, r 2 =0.9567. Dashed line, linear regression was used, r 2 =0.9998, p=0.008. All error bars represent standard error (s.e.) of at least three independent tests; *P<0.05, **P<0.01, ***P<0.001, ns, not significant. student's t-test(a), two-way ANOVA (b, c).
Figure S4 | Related to Figure 4 Bub1 is involved in regulation of endocytosis.
A, Endocytosis component-deficient flies were resistance to DCV infection compared to wild-type (w 1118 ) flies. Heterozygote flies were obtained by crossing with w 1118 virgin. B, bub1 mRNA expression of the whole body before or after DCV infection, measured by qRT-PCR and normalized to the wild type control. C, bub1 overexpression in S2 * cells had no effect on DCV entry ability (30min post infection). DCV entry ability indicated by DCV genome RNA level in S2 * cells quantified by qRT-PCR and normalized to vehicle plasmid transfected cells. D, DCV genome level of indicated cells measured by qRT-PCR at 12h post infection, normalized to that of control. All error bars represent standard error (s.e.) of at least three independent tests; n>60 flies (a) for each line or n>15 (b) for each time point. *P<0.05, **P<0.01, ***P<0.001, ns, not significant. Kaplan-Meier (a), or student's t-test (b, c, d).
Figure S5 | Survival rates of flies after VSV infection.
A, Survival rates of wild-type (w 1118 ) flies and bub1 c04512 mutant flies post VSV-GFP injection. All error bars represent standard error (s.e.) of at least three independent tests; n>60 flies (a). *P<0.05, **P<0.01, ***P<0.001, ns, not significant. Kaplan-Meier (a).
Figure S6 | 2OH-BNPP1 affects DCV replication.
A, Inhibition of Bub1 kinase activity by high level of 2OH-BNPP1 reduced DCV loads. DCV RNA level of indicated cells measured by qRT-PCR at the indicated time and was normalized to that of DMSO treated cells. B, 40uM 2OH-BNPP1 treatment had no impact on Bub1/AP-1-2-beta interaction upon DCV infection. All error bars represent standard error (s.e.) of at least three independent tests; *P<0.05, **P<0.01, ***P<0.001, ns, not significant. two-way ANOVA (a). 1 1 d 1 2 d 1 3 d 1 4 
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